Concepts (277)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 39 | 2023 | 83 | 16.720 |
Why?
|
| Firefighters | 9 | 2019 | 13 | 5.060 |
Why?
|
| Smoke Inhalation Injury | 5 | 2021 | 5 | 2.320 |
Why?
|
| Accidents, Occupational | 3 | 2019 | 16 | 1.770 |
Why?
|
| Occupational Injuries | 3 | 2019 | 9 | 1.760 |
Why?
|
| Burn Units | 11 | 2019 | 14 | 1.660 |
Why?
|
| Registries | 3 | 2019 | 733 | 1.540 |
Why?
|
| Wound Infection | 3 | 2021 | 20 | 1.470 |
Why?
|
| Blast Injuries | 2 | 2023 | 15 | 1.430 |
Why?
|
| Skin Transplantation | 4 | 2020 | 45 | 1.430 |
Why?
|
| Ketamine | 2 | 2019 | 57 | 1.260 |
Why?
|
| Burns, Chemical | 2 | 2019 | 7 | 1.230 |
Why?
|
| Electronic Nicotine Delivery Systems | 2 | 2023 | 180 | 1.180 |
Why?
|
| Fires | 3 | 2021 | 21 | 1.070 |
Why?
|
| Bandages | 4 | 2019 | 33 | 1.050 |
Why?
|
| Databases, Factual | 5 | 2019 | 622 | 0.990 |
Why?
|
| Injury Severity Score | 5 | 2019 | 204 | 0.990 |
Why?
|
| Occupational Health | 4 | 2019 | 41 | 0.980 |
Why?
|
| Retrospective Studies | 17 | 2023 | 7277 | 0.980 |
Why?
|
| Facial Injuries | 3 | 2021 | 10 | 0.950 |
Why?
|
| Point-of-Care Systems | 2 | 2016 | 115 | 0.930 |
Why?
|
| Adult | 28 | 2022 | 21403 | 0.920 |
Why?
|
| Mafenide | 3 | 2018 | 3 | 0.900 |
Why?
|
| Ascorbic Acid | 2 | 2015 | 45 | 0.880 |
Why?
|
| Anti-Infective Agents, Local | 3 | 2018 | 40 | 0.870 |
Why?
|
| Humans | 46 | 2023 | 68618 | 0.870 |
Why?
|
| Male | 33 | 2023 | 37321 | 0.860 |
Why?
|
| Middle Aged | 23 | 2023 | 21147 | 0.840 |
Why?
|
| United States | 14 | 2019 | 7367 | 0.830 |
Why?
|
| Herpes Simplex | 1 | 2021 | 35 | 0.770 |
Why?
|
| Female | 29 | 2023 | 38074 | 0.760 |
Why?
|
| Analgesics | 2 | 2019 | 118 | 0.750 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 110 | 0.730 |
Why?
|
| Hospitalization | 3 | 2016 | 978 | 0.720 |
Why?
|
| Bupivacaine | 1 | 2020 | 27 | 0.710 |
Why?
|
| Resuscitation | 2 | 2011 | 77 | 0.710 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2018 | 133 | 0.690 |
Why?
|
| Respiration, Artificial | 2 | 2017 | 190 | 0.690 |
Why?
|
| Staphylococcus aureus | 2 | 2018 | 175 | 0.680 |
Why?
|
| Anesthetics, Local | 1 | 2020 | 83 | 0.680 |
Why?
|
| Personal Protective Equipment | 1 | 2019 | 27 | 0.680 |
Why?
|
| Lubricants | 1 | 2019 | 1 | 0.680 |
Why?
|
| Poloxamer | 1 | 2019 | 10 | 0.670 |
Why?
|
| Inhalant Abuse | 1 | 2019 | 7 | 0.670 |
Why?
|
| Data Collection | 2 | 2018 | 420 | 0.670 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2019 | 49 | 0.650 |
Why?
|
| Airway Obstruction | 1 | 2019 | 49 | 0.650 |
Why?
|
| Phosphates | 2 | 2016 | 72 | 0.640 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 214 | 0.610 |
Why?
|
| Albuterol | 1 | 2017 | 26 | 0.600 |
Why?
|
| Laryngoscopy | 1 | 2017 | 61 | 0.590 |
Why?
|
| Body Surface Area | 5 | 2019 | 20 | 0.580 |
Why?
|
| Accident Prevention | 1 | 2017 | 5 | 0.570 |
Why?
|
| Pain Management | 1 | 2019 | 186 | 0.570 |
Why?
|
| Heparin | 1 | 2017 | 205 | 0.560 |
Why?
|
| Health Personnel | 2 | 2020 | 286 | 0.560 |
Why?
|
| Laxatives | 1 | 2016 | 4 | 0.560 |
Why?
|
| Biological Dressings | 1 | 2016 | 4 | 0.550 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2016 | 11 | 0.550 |
Why?
|
| Propranolol | 1 | 2016 | 103 | 0.540 |
Why?
|
| Dermatitis | 1 | 2016 | 28 | 0.530 |
Why?
|
| Mortality | 1 | 2017 | 163 | 0.530 |
Why?
|
| Self-Injurious Behavior | 1 | 2016 | 31 | 0.520 |
Why?
|
| Leg Injuries | 2 | 2017 | 18 | 0.520 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2016 | 189 | 0.510 |
Why?
|
| Quality of Health Care | 2 | 2015 | 322 | 0.510 |
Why?
|
| Hypophosphatemia | 1 | 2015 | 6 | 0.510 |
Why?
|
| Attitude of Health Personnel | 2 | 2016 | 442 | 0.510 |
Why?
|
| Shock, Traumatic | 1 | 2015 | 4 | 0.510 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2016 | 100 | 0.500 |
Why?
|
| Blood Glucose | 2 | 2016 | 631 | 0.500 |
Why?
|
| Critical Care | 2 | 2015 | 263 | 0.500 |
Why?
|
| Social Media | 1 | 2016 | 59 | 0.490 |
Why?
|
| Analgesics, Opioid | 3 | 2019 | 498 | 0.490 |
Why?
|
| Protective Devices | 2 | 2012 | 13 | 0.490 |
Why?
|
| Protective Clothing | 1 | 2014 | 12 | 0.490 |
Why?
|
| Physician Assistants | 1 | 2015 | 47 | 0.480 |
Why?
|
| Acetylcysteine | 1 | 2017 | 296 | 0.480 |
Why?
|
| Fluid Therapy | 2 | 2016 | 59 | 0.480 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 100 | 0.480 |
Why?
|
| General Surgery | 1 | 2015 | 95 | 0.470 |
Why?
|
| Nurse Practitioners | 1 | 2015 | 90 | 0.470 |
Why?
|
| Health Care Surveys | 1 | 2015 | 239 | 0.470 |
Why?
|
| Intensive Care Units | 5 | 2017 | 344 | 0.460 |
Why?
|
| Hyperglycemia | 1 | 2015 | 158 | 0.440 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2013 | 69 | 0.430 |
Why?
|
| Amish | 1 | 2012 | 2 | 0.430 |
Why?
|
| Medicine, Traditional | 1 | 2012 | 7 | 0.430 |
Why?
|
| Curriculum | 2 | 2020 | 575 | 0.430 |
Why?
|
| Plant Preparations | 1 | 2012 | 18 | 0.430 |
Why?
|
| Treatment Refusal | 1 | 2012 | 40 | 0.420 |
Why?
|
| Complementary Therapies | 1 | 2012 | 43 | 0.420 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 378 | 0.410 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 504 | 0.400 |
Why?
|
| Swine | 3 | 2019 | 672 | 0.400 |
Why?
|
| Surveys and Questionnaires | 6 | 2020 | 2800 | 0.390 |
Why?
|
| Population Surveillance | 1 | 2013 | 285 | 0.390 |
Why?
|
| Fentanyl | 1 | 2011 | 26 | 0.380 |
Why?
|
| Chondroitin Sulfates | 1 | 2011 | 44 | 0.370 |
Why?
|
| Narcotics | 1 | 2011 | 65 | 0.370 |
Why?
|
| Morphine | 1 | 2011 | 76 | 0.370 |
Why?
|
| Body Temperature | 1 | 2011 | 116 | 0.360 |
Why?
|
| Risk Assessment | 4 | 2019 | 2007 | 0.360 |
Why?
|
| Career Choice | 1 | 2011 | 98 | 0.350 |
Why?
|
| Aged | 8 | 2023 | 14862 | 0.350 |
Why?
|
| Length of Stay | 3 | 2019 | 780 | 0.350 |
Why?
|
| Hydroxocobalamin | 2 | 2021 | 3 | 0.340 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 807 | 0.340 |
Why?
|
| Internship and Residency | 1 | 2015 | 596 | 0.340 |
Why?
|
| Lower Extremity | 1 | 2011 | 153 | 0.330 |
Why?
|
| Cohort Studies | 5 | 2019 | 2358 | 0.320 |
Why?
|
| Hypnotics and Sedatives | 2 | 2019 | 96 | 0.320 |
Why?
|
| Antioxidants | 1 | 2011 | 304 | 0.320 |
Why?
|
| Students, Medical | 1 | 2011 | 210 | 0.310 |
Why?
|
| Age Distribution | 3 | 2015 | 320 | 0.310 |
Why?
|
| Logistic Models | 4 | 2017 | 1420 | 0.310 |
Why?
|
| Incidence | 3 | 2019 | 1603 | 0.300 |
Why?
|
| Collagen | 1 | 2011 | 636 | 0.300 |
Why?
|
| Physicians | 1 | 2011 | 324 | 0.290 |
Why?
|
| Skin | 3 | 2019 | 451 | 0.280 |
Why?
|
| Infusions, Intravenous | 2 | 2019 | 334 | 0.280 |
Why?
|
| Primary Prevention | 2 | 2021 | 115 | 0.280 |
Why?
|
| Pain Measurement | 2 | 2019 | 328 | 0.280 |
Why?
|
| Cause of Death | 2 | 2019 | 241 | 0.270 |
Why?
|
| Risk Factors | 4 | 2019 | 5731 | 0.260 |
Why?
|
| Child, Preschool | 4 | 2016 | 3187 | 0.250 |
Why?
|
| Guideline Adherence | 2 | 2019 | 287 | 0.250 |
Why?
|
| Algorithms | 1 | 2010 | 1196 | 0.240 |
Why?
|
| Cyanides | 2 | 2021 | 15 | 0.240 |
Why?
|
| Smoking | 2 | 2023 | 1452 | 0.230 |
Why?
|
| Antidotes | 2 | 2021 | 21 | 0.230 |
Why?
|
| Case-Control Studies | 3 | 2016 | 1553 | 0.220 |
Why?
|
| Critical Illness | 2 | 2015 | 191 | 0.220 |
Why?
|
| Prognosis | 2 | 2021 | 2093 | 0.200 |
Why?
|
| Stroke | 1 | 2015 | 2163 | 0.200 |
Why?
|
| APACHE | 2 | 2011 | 41 | 0.190 |
Why?
|
| Oxygen | 1 | 2023 | 386 | 0.190 |
Why?
|
| Isotonic Solutions | 2 | 2011 | 25 | 0.190 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 306 | 0.180 |
Why?
|
| Simulation Training | 1 | 2020 | 49 | 0.180 |
Why?
|
| Respiratory Protective Devices | 1 | 2019 | 1 | 0.180 |
Why?
|
| Ear Protective Devices | 1 | 2019 | 2 | 0.180 |
Why?
|
| Clothing | 1 | 2019 | 7 | 0.180 |
Why?
|
| Gloves, Protective | 1 | 2019 | 6 | 0.170 |
Why?
|
| Intraoperative Care | 1 | 2020 | 91 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 2 | 2019 | 504 | 0.170 |
Why?
|
| Analgesia | 1 | 2020 | 58 | 0.170 |
Why?
|
| Liposomes | 1 | 2020 | 107 | 0.170 |
Why?
|
| Mineral Oil | 1 | 2019 | 1 | 0.170 |
Why?
|
| Gels | 1 | 2019 | 55 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2021 | 211 | 0.170 |
Why?
|
| Glycerol | 1 | 2019 | 26 | 0.170 |
Why?
|
| Midazolam | 1 | 2019 | 46 | 0.160 |
Why?
|
| Southeastern United States | 1 | 2019 | 281 | 0.160 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 481 | 0.160 |
Why?
|
| Conscious Sedation | 1 | 2019 | 61 | 0.160 |
Why?
|
| Administration, Oral | 1 | 2019 | 411 | 0.160 |
Why?
|
| Cell Death | 1 | 2019 | 329 | 0.150 |
Why?
|
| Thermography | 1 | 2018 | 20 | 0.150 |
Why?
|
| Tachypnea | 1 | 2017 | 1 | 0.150 |
Why?
|
| Diagnostic Techniques, Respiratory System | 1 | 2017 | 2 | 0.150 |
Why?
|
| Internationality | 1 | 2018 | 74 | 0.150 |
Why?
|
| Burns, Inhalation | 1 | 2017 | 3 | 0.150 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2017 | 34 | 0.150 |
Why?
|
| Nose | 1 | 2017 | 36 | 0.150 |
Why?
|
| Ear Canal | 1 | 2017 | 24 | 0.150 |
Why?
|
| Adolescent | 4 | 2016 | 8912 | 0.150 |
Why?
|
| Canada | 1 | 2018 | 267 | 0.150 |
Why?
|
| Larynx | 1 | 2017 | 49 | 0.150 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 62 | 0.150 |
Why?
|
| Administration, Inhalation | 1 | 2017 | 187 | 0.140 |
Why?
|
| Wounds, Gunshot | 1 | 2017 | 48 | 0.140 |
Why?
|
| Explosions | 1 | 2017 | 4 | 0.140 |
Why?
|
| Self Care | 1 | 2019 | 253 | 0.140 |
Why?
|
| Pharynx | 1 | 2017 | 89 | 0.140 |
Why?
|
| Dyspnea | 1 | 2017 | 87 | 0.140 |
Why?
|
| Hand Injuries | 1 | 2017 | 9 | 0.140 |
Why?
|
| Young Adult | 4 | 2018 | 5717 | 0.140 |
Why?
|
| Vitamin B Complex | 1 | 2016 | 26 | 0.140 |
Why?
|
| Perineum | 1 | 2016 | 11 | 0.140 |
Why?
|
| Hypoxia | 1 | 2017 | 169 | 0.140 |
Why?
|
| Buttocks | 1 | 2016 | 16 | 0.140 |
Why?
|
| Silver Compounds | 1 | 2016 | 5 | 0.140 |
Why?
|
| Analysis of Variance | 1 | 2019 | 1040 | 0.140 |
Why?
|
| Bicarbonates | 1 | 2016 | 21 | 0.140 |
Why?
|
| Trauma Severity Indices | 1 | 2016 | 80 | 0.140 |
Why?
|
| Blood Urea Nitrogen | 1 | 2016 | 65 | 0.140 |
Why?
|
| Chlorides | 1 | 2016 | 68 | 0.140 |
Why?
|
| Urine | 1 | 2016 | 47 | 0.140 |
Why?
|
| Graft Survival | 1 | 2019 | 465 | 0.140 |
Why?
|
| Constipation | 1 | 2016 | 32 | 0.130 |
Why?
|
| Professional Competence | 1 | 2017 | 100 | 0.130 |
Why?
|
| Animals | 3 | 2019 | 20881 | 0.130 |
Why?
|
| Potassium | 1 | 2016 | 168 | 0.130 |
Why?
|
| Sodium | 1 | 2016 | 161 | 0.130 |
Why?
|
| Magnesium | 1 | 2016 | 110 | 0.130 |
Why?
|
| Graft Rejection | 1 | 2019 | 458 | 0.130 |
Why?
|
| Creatinine | 1 | 2016 | 243 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2019 | 1342 | 0.130 |
Why?
|
| Pneumonia | 1 | 2016 | 110 | 0.130 |
Why?
|
| Double-Blind Method | 1 | 2019 | 1738 | 0.130 |
Why?
|
| Needs Assessment | 1 | 2017 | 186 | 0.130 |
Why?
|
| Awareness | 1 | 2016 | 81 | 0.130 |
Why?
|
| Surgeons | 1 | 2016 | 68 | 0.130 |
Why?
|
| Pain | 2 | 2016 | 472 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2020 | 657 | 0.120 |
Why?
|
| Water-Electrolyte Balance | 1 | 2015 | 43 | 0.120 |
Why?
|
| Blood Chemical Analysis | 1 | 2015 | 43 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2017 | 714 | 0.120 |
Why?
|
| Anticoagulants | 1 | 2017 | 356 | 0.120 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 1753 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1745 | 0.120 |
Why?
|
| Clinical Protocols | 1 | 2015 | 172 | 0.120 |
Why?
|
| Organizational Culture | 1 | 2014 | 59 | 0.120 |
Why?
|
| Hypoglycemia | 1 | 2015 | 72 | 0.120 |
Why?
|
| Workload | 1 | 2015 | 103 | 0.120 |
Why?
|
| Ambulatory Care | 1 | 2016 | 340 | 0.120 |
Why?
|
| Cells, Cultured | 1 | 2019 | 2673 | 0.110 |
Why?
|
| Telemedicine | 1 | 2022 | 700 | 0.110 |
Why?
|
| Video Recording | 1 | 2014 | 145 | 0.110 |
Why?
|
| Program Evaluation | 1 | 2016 | 502 | 0.110 |
Why?
|
| Wound Healing | 2 | 2017 | 260 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1140 | 0.110 |
Why?
|
| Child | 4 | 2022 | 6405 | 0.110 |
Why?
|
| Religion and Medicine | 1 | 2012 | 25 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2012 | 164 | 0.100 |
Why?
|
| Calcium | 1 | 2016 | 929 | 0.100 |
Why?
|
| Time Factors | 2 | 2018 | 4655 | 0.100 |
Why?
|
| Isoantibodies | 1 | 2011 | 35 | 0.100 |
Why?
|
| Internet | 1 | 2014 | 390 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 772 | 0.100 |
Why?
|
| Informed Consent | 1 | 2012 | 127 | 0.100 |
Why?
|
| Hemostatics | 1 | 2011 | 47 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2017 | 7029 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2012 | 274 | 0.100 |
Why?
|
| Thrombin | 1 | 2011 | 117 | 0.090 |
Why?
|
| Blood Loss, Surgical | 1 | 2011 | 79 | 0.090 |
Why?
|
| Urination | 1 | 2011 | 19 | 0.090 |
Why?
|
| Positive-Pressure Respiration | 1 | 2011 | 27 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2077 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 767 | 0.090 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 742 | 0.090 |
Why?
|
| Infant | 2 | 2013 | 2891 | 0.080 |
Why?
|
| Sex Factors | 1 | 2013 | 1266 | 0.080 |
Why?
|
| Household Articles | 1 | 2009 | 2 | 0.080 |
Why?
|
| Accidents, Home | 1 | 2009 | 9 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 234 | 0.080 |
Why?
|
| Survival Rate | 1 | 2012 | 1056 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2011 | 737 | 0.080 |
Why?
|
| Brain | 1 | 2019 | 2176 | 0.080 |
Why?
|
| Body Weight | 1 | 2010 | 554 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1465 | 0.080 |
Why?
|
| Hemodynamics | 1 | 2011 | 705 | 0.080 |
Why?
|
| Comorbidity | 1 | 2011 | 1426 | 0.070 |
Why?
|
| Administration, Topical | 2 | 2017 | 111 | 0.060 |
Why?
|
| Outpatients | 1 | 2022 | 127 | 0.050 |
Why?
|
| Drug Stability | 1 | 2018 | 71 | 0.040 |
Why?
|
| Pandemics | 1 | 2022 | 352 | 0.040 |
Why?
|
| Infrared Rays | 1 | 2018 | 12 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 438 | 0.040 |
Why?
|
| Multiple Trauma | 1 | 2017 | 50 | 0.040 |
Why?
|
| Ear Diseases | 1 | 2017 | 37 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 236 | 0.040 |
Why?
|
| Cost Savings | 1 | 2017 | 110 | 0.030 |
Why?
|
| Patient Selection | 1 | 2018 | 592 | 0.030 |
Why?
|
| Hemostatic Techniques | 1 | 2011 | 23 | 0.020 |
Why?
|
| Pruritus | 1 | 2011 | 35 | 0.020 |
Why?
|
| Epinephrine | 1 | 2011 | 103 | 0.020 |
Why?
|
| Postoperative Hemorrhage | 1 | 2011 | 69 | 0.020 |
Why?
|
| Anemia | 1 | 2011 | 104 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 507 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 649 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 951 | 0.020 |
Why?
|
| Equipment Safety | 1 | 2009 | 50 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 2324 | 0.020 |
Why?
|
| Equipment Design | 1 | 2009 | 500 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2011 | 1615 | 0.010 |
Why?
|